Apogee Therapeutics shares owned by Barclays
Quarter-by-quarter ownership of Apogee Therapeutics (APGE) shares owned by Barclays
from 13F filings
Historical chart of Barclays investment in Apogee Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Apogee Therapeutics held by Barclays consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Apogee Therapeutics by Barclays
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $26M | 642k | 39.73 |
| 2025-06-30 | $26M | 609k | 43.43 |
| 2025-03-31 | $19M | 499k | 37.36 |
| 2024-12-31 | $22M | 477k | 45.30 |
| 2024-09-30 | $21M | 365k | 58.74 |
| 2024-06-30 | $3.1M | 78k | 39.34 |
| 2024-03-31 | $2.4M | 37k | 66.47 |
| 2023-12-31 | $952k | 34k | 27.95 |